Motivations and psychosocial impact of genetic testing for HNPCC

被引:38
作者
Esplen, MJ
Madlensky, L
Butler, K
McKinnon, W
Bapat, B
Wong, JH
Aronson, M
Gallinger, S
机构
[1] Mt Sinai Hosp, Dept Psychiat, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Fac Med, Dept Psychiat, Toronto, ON M5S 1A1, Canada
[3] Natl Canc Inst Canada, Toronto, ON, Canada
[4] Vermont Canc Ctr, Familial Canc Program, Burlington, VT USA
[5] Mt Sinai Hosp, Dept Lab Med & Pathobiol, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[6] Mt Sinai Hosp, Familial GI Canc Registry, Toronto, ON M5G 1X5, Canada
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2001年 / 103卷 / 01期
关键词
HNPCC; genetic testing; psychosocial adaptation; motivations; CRC;
D O I
10.1002/ajmg.1493
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A type of hereditary colorectal cancer (CRC) known as hereditary nonpolyposis colorectal cancer (HNPCC) is associated with MLH1 and MSH2 gene mutations. This study consists of a pilot, cross-sectional study of 50 individuals who were engaged in the genetic testing process for HNPCC. The study investigated the motivations and attitudes around genetic testing and current psychosocial functioning through the use of standardized measures, as well as obtained in-formation on disclosure patterns associated with test results. The mean age of the sample was 44.3 years. (SD = 15.0). Twenty-three individuals were identified as "carriers" (13 had a previous history of CRC), seven were "non-carriers" and 20 individuals were still awaiting test results. The primary motivations for participating in genetic testing were similar to previous reports and included: wanting to know if more screening tests were needed, obtaining information about the risk for offspring and increasing certainty around their own risk. The psychosocial scores demonstrated that a subgroup of individuals exhibited distress, with greater distress for those individuals awaiting results or testing positive. There was a high level of satisfaction associated with the experience of testing. Individuals in this study tended to disclose their test results to a variety of family and non-family members. Disclosure was primarily associated with positive experiences however, some individuals reported regret around disclosure of their results. These preliminary findings should be further explored in a larger prospective study design over multiple time points. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 35 条
[1]  
AALTONEN LA, 1994, CANCER DETECT PREV, V18, P57
[2]  
[Anonymous], J HLTH CARE LAW POLI
[3]   Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer [J].
Bapat, BV ;
Madlensky, L ;
Temple, LKF ;
Hiruki, T ;
Redston, M ;
Baron, DL ;
Xia, L ;
Marcus, VA ;
Soravia, C ;
Mitri, A ;
Shen, W ;
Gryfe, R ;
Berk, T ;
Chodirker, BN ;
Cohen, Z ;
Gallinger, S .
HUMAN GENETICS, 1999, 104 (02) :167-176
[4]   Stress and genetic testing for disease risk [J].
Baum, A ;
Friedman, AL ;
Zakowski, SG .
HEALTH PSYCHOLOGY, 1997, 16 (01) :8-19
[5]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .1. Hereditary nonpolyposis colon cancer [J].
Burke, W ;
Petersen, G ;
Lynch, P ;
Botkin, J ;
Daly, M ;
Garber, J ;
Kahn, MJE ;
McTiernan, A ;
Offit, K ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (11) :915-919
[6]  
Codori AM, 1999, CANCER EPIDEM BIOMAR, V8, P345
[7]   Psychological responses to BRCA1 mutation testing: Preliminary findings [J].
Croyle, RT ;
Smith, KR ;
Botkin, JR ;
Baty, B ;
Nash, J .
HEALTH PSYCHOLOGY, 1997, 16 (01) :63-72
[8]   INTEREST IN GENETIC TESTING FOR COLON CANCER SUSCEPTIBILITY - COGNITIVE AND EMOTIONAL CORRELATES [J].
CROYLE, RT ;
LERMAN, C .
PREVENTIVE MEDICINE, 1993, 22 (02) :284-292
[9]   Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders [J].
DudokdeWit, AC ;
Tibben, A ;
Duivenvoorden, HJ ;
Frets, PG ;
Zoeteweij, MW ;
Losekoot, M ;
vanHaeringen, A ;
Niermeijer, MF ;
Passchier, J ;
Lindhout, D ;
MeijersHeijboer, EJ ;
Lodder, LN ;
Trijsburg, RW ;
Klijn, JGM ;
BrockerVriends, A ;
Helderman, ATJM ;
HilhorstHofstee, Y ;
Kant, S ;
MaatKievit, JA ;
Oosterwijk, JC ;
vanderSmagt, JJ ;
VegtervanderVlis, M ;
VriesvanderWeerd, MACS ;
Bakker, E ;
Cornelisse, CJ ;
Devilee, P ;
Tops, C ;
Vasen, HFA .
JOURNAL OF MEDICAL GENETICS, 1997, 34 (05) :382-390
[10]  
Geller G, 1999, CANCER EPIDEM BIOMAR, V8, P377